COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 40,984 | 471,835 | SH | | SOLE | | 471,835 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 30,185 | 340,916 | SH | | SOLE | | 340,916 | 0 | 0 |
ABIOMED, Inc. | Common | 003654100 | 5,581 | 32,716 | SH | | SOLE | | 32,716 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 1,464 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 4,525 | 136,200 | SH | | SOLE | | 136,200 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 9,338 | 218,283 | SH | | SOLE | | 218,283 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 4,576 | 86,313 | SH | | SOLE | | 86,313 | 0 | 0 |
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 92 | 77,061 | SH | | SOLE | | 77,061 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 1,612 | 66,688 | SH | | SOLE | | 66,688 | 0 | 0 |
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 161 | 257,554 | SH | | SOLE | | 257,554 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 2,331 | 27,325 | SH | | SOLE | | 27,325 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 10,333 | 216,408 | SH | | SOLE | | 216,408 | 0 | 0 |
Alcon Inc. | Ordinary Shares | H01301128 | 3,132 | 55,369 | SH | | SOLE | | 55,369 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 47,133 | 435,814 | SH | | SOLE | | 435,814 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 6,244 | 22,378 | SH | | SOLE | | 22,378 | 0 | 0 |
Alkermes Public Limited Company | Shares | G01767105 | 4,040 | 198,048 | SH | | SOLE | | 198,048 | 0 | 0 |
Allakos Inc. | Common | 01671P100 | 6,808 | 71,396 | SH | | SOLE | | 71,396 | 0 | 0 |
Allergan Public Limited Company | Shares | G0177J108 | 30,507 | 159,581 | SH | | SOLE | | 159,581 | 0 | 0 |
Allogene Therapeutics, Inc. | Common | 019770106 | 2,086 | 80,280 | SH | | SOLE | | 80,280 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 16,561 | 143,795 | SH | | SOLE | | 143,795 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 8,750 | 408,120 | SH | | SOLE | | 408,120 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 9,839 | 115,723 | SH | | SOLE | | 115,723 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 148,843 | 617,427 | SH | | SOLE | | 617,427 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 3,594 | 368,960 | SH | | SOLE | | 368,960 | 0 | 0 |
AnaptysBio, Inc. | Common | 032724106 | 1,922 | 118,261 | SH | | SOLE | | 118,261 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 30,817 | 102,032 | SH | | SOLE | | 102,032 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 4,011 | 130,999 | SH | | SOLE | | 130,999 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 206 | 36,068 | SH | | SOLE | | 36,068 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 4,561 | 607,698 | SH | | SOLE | | 607,698 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 1,272 | 28,002 | SH | | SOLE | | 28,002 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 7,220 | 44,977 | SH | | SOLE | | 44,977 | 0 | 0 |
ArQule, Inc. | Common | 04269E107 | 4,399 | 220,409 | SH | | SOLE | | 220,409 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 6,685 | 105,398 | SH | | SOLE | | 105,398 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 9,645 | 69,332 | SH | | SOLE | | 69,332 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 13,766 | 276,098 | SH | | SOLE | | 276,098 | 0 | 0 |
Atreca, Inc. | Class A Common | 04965G109 | 8,120 | 524,896 | SH | | SOLE | | 524,896 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 1,839 | 90,788 | SH | | SOLE | | 90,788 | 0 | 0 |
Avadel Pharmaceuticals Public Limited Company | Sponsored ADR | 05337M104 | 6,150 | 814,588 | SH | | SOLE | | 814,588 | 0 | 0 |
AVROBIO, Inc. | Common | 05455M100 | 1,507 | 74,874 | SH | | SOLE | | 74,874 | 0 | 0 |
Axonics Modulation Technologies, Inc. | Common | 05465P101 | 779 | 28,100 | SH | | SOLE | | 28,100 | 0 | 0 |
Bausch Health Companies Inc. | Common | 071734107 | 4,153 | 138,812 | SH | | SOLE | | 138,812 | 0 | 0 |
Baxter International Inc. | Common | 071813109 | 10,869 | 129,983 | SH | | SOLE | | 129,983 | 0 | 0 |
Becton, Dickinson and Company | Common | 075887109 | 18,020 | 66,257 | SH | | SOLE | | 66,257 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 13,441 | 81,089 | SH | | SOLE | | 81,089 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 77 | 60,000 | SH | | SOLE | | 60,000 | 0 | 0 |
Bio-Techne Corporation | Common | 09073M104 | 10,995 | 50,091 | SH | | SOLE | | 50,091 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 84,605 | 285,126 | SH | | SOLE | | 285,126 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 1,586 | 29,125 | SH | | SOLE | | 29,125 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 23,383 | 276,560 | SH | | SOLE | | 276,560 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 8,397 | 95,687 | SH | | SOLE | | 95,687 | 0 | 0 |
Blueprint Medicines Corporation | Common | 09627Y109 | 9,367 | 116,925 | SH | | SOLE | | 116,925 | 0 | 0 |
Boston Scientific Corporation | Common | 101137107 | 25,520 | 564,345 | SH | | SOLE | | 564,345 | 0 | 0 |
BridgeBio Pharma, Inc. | Common | 10806X102 | 1,375 | 39,228 | SH | | SOLE | | 39,228 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 49,738 | 774,862 | SH | | SOLE | | 774,862 | 0 | 0 |
Bristol-Myers Squibb Company | Right | 110122157 | 4,436 | 1,473,710 | SH | | SOLE | | 1,473,710 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B202 | 16 | 7,053 | SH | | SOLE | | 7,053 | 0 | 0 |
Cellectis | Sponsored ADR | 15117K103 | 1,886 | 110,147 | SH | | SOLE | | 110,147 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 9,401 | 149,526 | SH | | SOLE | | 149,526 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 3,203 | 20,967 | SH | | SOLE | | 20,967 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 610 | 158,784 | SH | | SOLE | | 158,784 | 0 | 0 |
Cigna Corporation | Common | 125523100 | 38,967 | 190,555 | SH | | SOLE | | 190,555 | 0 | 0 |
Clearside Biomedical, Inc. | Common | 185063104 | 479 | 165,330 | SH | | SOLE | | 165,330 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 2,253 | 125,146 | SH | | SOLE | | 125,146 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 591 | 203,935 | SH | | SOLE | | 203,935 | 0 | 0 |
Community Healthcare Trust Incorporated | Common | 20369C106 | 639 | 14,900 | SH | | SOLE | | 14,900 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 4,642 | 76,222 | SH | | SOLE | | 76,222 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 36,995 | 497,986 | SH | | SOLE | | 497,986 | 0 | 0 |
CymaBay Therapeutics, Inc. | Common | 23257D103 | 173 | 88,102 | SH | | SOLE | | 88,102 | 0 | 0 |
Danaher Corporation | Common | 235851102 | 25,397 | 165,476 | SH | | SOLE | | 165,476 | 0 | 0 |
Deciphera Pharmaceuticals, Inc. | Common | 24344T101 | 3,820 | 61,370 | SH | | SOLE | | 61,370 | 0 | 0 |
DENTSPLY SIRONA Inc. | Common | 24906P109 | 6,776 | 119,736 | SH | | SOLE | | 119,736 | 0 | 0 |
Dermira, Inc. | Common | 24983L104 | 1,352 | 89,200 | SH | | SOLE | | 89,200 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 3,019 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Editas Medicine, Inc. | Common | 28106W103 | 4,380 | 147,939 | SH | | SOLE | | 147,939 | 0 | 0 |
Edwards Lifesciences Corporation | Common | 28176E108 | 16,227 | 69,557 | SH | | SOLE | | 69,557 | 0 | 0 |
Eidos Therapeutics, Inc. | Common | 28249H104 | 1,148 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 27,624 | 210,181 | SH | | SOLE | | 210,181 | 0 | 0 |
Endo International plc | Shares | G30401106 | 2,493 | 531,570 | SH | | SOLE | | 531,570 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 8,686 | 353,102 | SH | | SOLE | | 353,102 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 12,735 | 213,562 | SH | | SOLE | | 213,562 | 0 | 0 |
Evolent Health, Inc. | Common | 30050B101 | 2,091 | 231,027 | SH | | SOLE | | 231,027 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 9,077 | 515,125 | SH | | SOLE | | 515,125 | 0 | 0 |
Fate Therapeutics, Inc. | Common | 31189P102 | 3,242 | 165,672 | SH | | SOLE | | 165,672 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 8,332 | 194,270 | SH | | SOLE | | 194,270 | 0 | 0 |
Foamix Pharmaceuticals Ltd | Shares | M46135105 | 1,002 | 300,781 | SH | | SOLE | | 300,781 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 1,353 | 6,543 | SH | | SOLE | | 6,543 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 5,483 | 416,666 | SH | | SOLE | | 416,666 | 0 | 0 |
Genmab A/S | Sponsored ADS | 372303206 | 369 | 16,520 | SH | | SOLE | | 16,520 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 122,850 | 1,890,576 | SH | | SOLE | | 1,890,576 | 0 | 0 |
GlaxoSmithKline PLC | Shares | 37733W105 | 12,079 | 257,048 | SH | | SOLE | | 257,048 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 11,698 | 147,168 | SH | | SOLE | | 147,168 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,562 | 118,092 | SH | | SOLE | | 118,092 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 339 | 4,333 | SH | | SOLE | | 4,333 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 5,239 | 50,101 | SH | | SOLE | | 50,101 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 14,165 | 95,833 | SH | | SOLE | | 95,833 | 0 | 0 |
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 5,477 | 53,773 | SH | | SOLE | | 53,773 | 0 | 0 |
Healthcare Realty Trust Incorporated | Common | 421946104 | 2,791 | 83,629 | SH | | SOLE | | 83,629 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,393 | 46,000 | SH | | SOLE | | 46,000 | 0 | 0 |
HealthEquity, Inc. | Common | 42226A107 | 2,356 | 31,810 | SH | | SOLE | | 31,810 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 4,431 | 128,537 | SH | | SOLE | | 128,537 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 1,406 | 59,842 | SH | | SOLE | | 59,842 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 2,229 | 42,701 | SH | | SOLE | | 42,701 | 0 | 0 |
Horizon Therapeutics Public Limited Company | Shares | G46188101 | 11,029 | 304,664 | SH | | SOLE | | 304,664 | 0 | 0 |
Humana Inc. | Common | 444859102 | 20,163 | 55,013 | SH | | SOLE | | 55,013 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 11,389 | 43,614 | SH | | SOLE | | 43,614 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 90,433 | 272,601 | SH | | SOLE | | 272,601 | 0 | 0 |
ImmunoGen, Inc. | Common | 45253H101 | 859 | 168,190 | SH | | SOLE | | 168,190 | 0 | 0 |
Immunomedics, Inc. | Common | 452907108 | 10,307 | 487,103 | SH | | SOLE | | 487,103 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 33,464 | 383,230 | SH | | SOLE | | 383,230 | 0 | 0 |
Inogen, Inc. | Common | 45780L104 | 3,513 | 51,406 | SH | | SOLE | | 51,406 | 0 | 0 |
Insmed Incorporated | Common | 457669307 | 3,935 | 164,786 | SH | | SOLE | | 164,786 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 808 | 55,050 | SH | | SOLE | | 55,050 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 4,265 | 34,414 | SH | | SOLE | | 34,414 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 3,233 | 94,238 | SH | | SOLE | | 94,238 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 22,867 | 38,683 | SH | | SOLE | | 38,683 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 12,682 | 209,924 | SH | | SOLE | | 209,924 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common | 462260100 | 6,740 | 243,483 | SH | | SOLE | | 243,483 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 5,534 | 35,815 | SH | | SOLE | | 35,815 | 0 | 0 |
iShares Nasdaq Biotechnology ETF | Nasdaq Biotech | 464287556 | 4,680 | 38,834 | SH | | SOLE | | 38,834 | 0 | 0 |
Jazz Pharmaceuticals Public Limited Company | Shares | G50871105 | 12,789 | 85,673 | SH | | SOLE | | 85,673 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 133,738 | 916,827 | SH | | SOLE | | 916,827 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 2,084 | 42,700 | SH | | SOLE | | 42,700 | 0 | 0 |
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 5,316 | 31,424 | SH | | SOLE | | 31,424 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 4,271 | 40,955 | SH | | SOLE | | 40,955 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 7,417 | 165,668 | SH | | SOLE | | 165,668 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 1,215 | 13,340 | SH | | SOLE | | 13,340 | 0 | 0 |
Magenta Therapeutics, Inc. | Common | 55910K108 | 254 | 16,757 | SH | | SOLE | | 16,757 | 0 | 0 |
Mallinckrodt public limited company | Sponsored ADR | G5785G107 | 115 | 32,980 | SH | | SOLE | | 32,980 | 0 | 0 |
Masimo Corporation | Common | 574795100 | 3,441 | 21,773 | SH | | SOLE | | 21,773 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 9,312 | 67,325 | SH | | SOLE | | 67,325 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 7,901 | 374,289 | SH | | SOLE | | 374,289 | 0 | 0 |
The Medicines Company | Common | 584688105 | 10,250 | 120,670 | SH | | SOLE | | 120,670 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 1,586 | 18,871 | SH | | SOLE | | 18,871 | 0 | 0 |
Medtronic Public Limited Company | Shares | G5960L103 | 53,414 | 470,812 | SH | | SOLE | | 470,812 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 110,175 | 1,211,384 | SH | | SOLE | | 1,211,384 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 299 | 21,215 | SH | | SOLE | | 21,215 | 0 | 0 |
Mettler-Toledo International Inc. | Common | 592688105 | 3,350 | 4,223 | SH | | SOLE | | 4,223 | 0 | 0 |
Milestone Pharmaceuticals Inc. | Common | 59935V107 | 11,954 | 746,653 | SH | | SOLE | | 746,653 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 9,133 | 70,873 | SH | | SOLE | | 70,873 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 592 | 42,313 | SH | | SOLE | | 42,313 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 692 | 19,390 | SH | | SOLE | | 19,390 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 20,875 | 1,038,554 | SH | | SOLE | | 1,038,554 | 0 | 0 |
MyoKardia, Inc. | Common | 62857M105 | 1,407 | 19,300 | SH | | SOLE | | 19,300 | 0 | 0 |
Myriad Genetics, Inc. | Common | 62855J104 | 512 | 18,805 | SH | | SOLE | | 18,805 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 6,123 | 283,679 | SH | | SOLE | | 283,679 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 20,750 | 193,042 | SH | | SOLE | | 193,042 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 1,209 | 158,047 | SH | | SOLE | | 158,047 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 19,984 | 211,047 | SH | | SOLE | | 211,047 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 114 | 28,550 | SH | | SOLE | | 28,550 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 12,813 | 221,364 | SH | | SOLE | | 221,364 | 0 | 0 |
NovoCure Limited | Ordinary Shares | G6674U108 | 9,054 | 107,438 | SH | | SOLE | | 107,438 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 12,061 | 284,795 | SH | | SOLE | | 284,795 | 0 | 0 |
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 1,547 | 372,733 | SH | | SOLE | | 372,733 | 0 | 0 |
Pacific Biosciences of California, Inc. | Common | 69404D108 | 2,547 | 495,495 | SH | | SOLE | | 495,495 | 0 | 0 |
PerkinElmer, Inc. | Common | 714046109 | 1,846 | 19,011 | SH | | SOLE | | 19,011 | 0 | 0 |
Perrigo Company Public Limited Company | Shares | G97822103 | 559 | 10,818 | SH | | SOLE | | 10,818 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 81,704 | 2,085,348 | SH | | SOLE | | 2,085,348 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 8,651 | 456,756 | SH | | SOLE | | 456,756 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 5,246 | 1,449,269 | SH | | SOLE | | 1,449,269 | 0 | 0 |
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 3,866 | 161,899 | SH | | SOLE | | 161,899 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 17,006 | 153,003 | SH | | SOLE | | 153,003 | 0 | 0 |
PTC Therapeutics, Inc. | Common | 69366J200 | 4,771 | 99,327 | SH | | SOLE | | 99,327 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 624 | 71,340 | SH | | SOLE | | 71,340 | 0 | 0 |
Quest Diagnostics Incorporated | Common | 74834L100 | 2,245 | 21,025 | SH | | SOLE | | 21,025 | 0 | 0 |
Quorum Health Corporation | Common | 74909E106 | 23 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Quotient Limited | Common | G73268107 | 2,473 | 260,030 | SH | | SOLE | | 260,030 | 0 | 0 |
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 2,620 | 55,829 | SH | | SOLE | | 55,829 | 0 | 0 |
Reata Pharmaceuticals, Inc. | Class A | 75615P103 | 5,399 | 26,412 | SH | | SOLE | | 26,412 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 75,575 | 201,277 | SH | | SOLE | | 201,277 | 0 | 0 |
REGENXBIO Inc. | Common | 75901B107 | 1,454 | 35,500 | SH | | SOLE | | 35,500 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 4,304 | 27,775 | SH | | SOLE | | 27,775 | 0 | 0 |
Revance Therapeutics, Inc. | Common | 761330109 | 1,393 | 85,840 | SH | | SOLE | | 85,840 | 0 | 0 |
Rocket Pharmaceuticals, Inc. | Common | 77313F106 | 4,724 | 207,555 | SH | | SOLE | | 207,555 | 0 | 0 |
Rubius Therapeutics, Inc. | Common | 78116T103 | 650 | 68,373 | SH | | SOLE | | 68,373 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 9,950 | 466,247 | SH | | SOLE | | 466,247 | 0 | 0 |
Sage Therapeutics Inc | Common | 78667J108 | 6,945 | 96,211 | SH | | SOLE | | 96,211 | 0 | 0 |
Sangamo Therapeutics, Inc. | Common | 800677106 | 1,254 | 149,835 | SH | | SOLE | | 149,835 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 9,369 | 186,640 | SH | | SOLE | | 186,640 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 23,437 | 181,623 | SH | | SOLE | | 181,623 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 31,623 | 276,766 | SH | | SOLE | | 276,766 | 0 | 0 |
Smith & Nephew plc | Shares | 83175M205 | 4,786 | 99,560 | SH | | SOLE | | 99,560 | 0 | 0 |
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 6,471 | 68,037 | SH | | SOLE | | 68,037 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 417 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 2,254 | 14,790 | SH | | SOLE | | 14,790 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 23,863 | 113,667 | SH | | SOLE | | 113,667 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 7,054 | 641,268 | SH | | SOLE | | 641,268 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 6,890 | 115,842 | SH | | SOLE | | 115,842 | 0 | 0 |
Takeda Pharmaceutical Company Limited | Sponsored ADS | 874060205 | 4,146 | 210,146 | SH | | SOLE | | 210,146 | 0 | 0 |
Teleflex Incorporated | Common | 879369106 | 5,875 | 15,608 | SH | | SOLE | | 15,608 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 4,314 | 113,436 | SH | | SOLE | | 113,436 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N204 | 121 | 42,965 | SH | | SOLE | | 42,965 | 0 | 0 |
Teva Pharmaceutical Industries Limited | Sponsored ADR | 881624209 | 7,701 | 785,851 | SH | | SOLE | | 785,851 | 0 | 0 |
Theravance Biopharma, Inc. | Common | G8807B106 | 3,048 | 117,725 | SH | | SOLE | | 117,725 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 40,092 | 123,408 | SH | | SOLE | | 123,408 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 459 | 446,099 | SH | | SOLE | | 446,099 | 0 | 0 |
Turning Point Therapeutics, Inc. | Common | 90041T108 | 354 | 5,677 | SH | | SOLE | | 5,677 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 4,163 | 97,480 | SH | | SOLE | | 97,480 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 5,102 | 71,191 | SH | | SOLE | | 71,191 | 0 | 0 |
United Therapeutics Corporation | Class B | 91307C102 | 4,765 | 54,094 | SH | | SOLE | | 54,094 | 0 | 0 |
Unitedhealth Group Incorporated | Common | 91324P102 | 73,151 | 248,829 | SH | | SOLE | | 248,829 | 0 | 0 |
Universal Health Realty Income Trust | Shares | 91359E105 | 674 | 5,742 | SH | | SOLE | | 5,742 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 11,051 | 191,388 | SH | | SOLE | | 191,388 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 1,581 | 275,000 | SH | | SOLE | | 275,000 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 108,115 | 493,789 | SH | | SOLE | | 493,789 | 0 | 0 |
WaVe Life Sciences Ltd. | Shares | Y95308105 | 802 | 100,012 | SH | | SOLE | | 100,012 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 15,673 | 191,646 | SH | | SOLE | | 191,646 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 5,098 | 148,231 | SH | | SOLE | | 148,231 | 0 | 0 |
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,271 | 96,961 | SH | | SOLE | | 96,961 | 0 | 0 |
Y-mAbs Therapeutics, Inc. | Common | 984241109 | 354 | 11,326 | SH | | SOLE | | 11,326 | 0 | 0 |
Zai Lab Limited | ADR | 98887Q104 | 1,561 | 37,523 | SH | | SOLE | | 37,523 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 9,530 | 63,671 | SH | | SOLE | | 63,671 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 25,197 | 190,384 | SH | | SOLE | | 190,384 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 5,615 | 107,703 | SH | | SOLE | | 107,703 | 0 | 0 |
Zymeworks Inc. | Common | 98985W102 | 691 | 15,192 | SH | | SOLE | | 15,192 | 0 | 0 |